1. Connexin43 hemichannels: A potential drug target for the treatment of diabetic retinopathy. Issue 8 (August 2019) Authors: Mugisho, Odunayo O.; Green, Colin R.; Zhang, Jie; Acosta, Monica L.; Rupenthal, Ilva D. Journal: Drug discovery today Issue: Volume 24:Issue 8(2019) Page Start: 1627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Depot formulations to sustain periocular drug delivery to the posterior eye segment. Issue 8 (August 2019) Authors: Agban, Yosra; Thakur, Sachin S.; Mugisho, Odunayo O.; Rupenthal, Ilva D. Journal: Drug discovery today Issue: Volume 24:Issue 8(2019) Page Start: 1458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ocular drugs and drug delivery systems — Current trends and future perspectives. Issue 8 (August 2019) Authors: Rupenthal, Ilva D.; Daugherty, Ann L. Journal: Drug discovery today Issue: Volume 24:Issue 8(2019) Page Start: 1425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Targeting connexin hemichannels to control the inflammasome: the correlation between connexin43 and NLRP3 expression in chronic eye disease. (3rd October 2019) Authors: Mugisho, Odunayo O.; Rupenthal, Ilva D.; Paquet-Durand, Francois; Acosta, Monica L.; Green, Colin R. Journal: Expert opinion on therapeutic targets Issue: Volume 23:Number 10(2019:Oct.) Page Start: 855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗